Reference
- Mathur G, et al. Coexistence of tyrosine kinase inhibitor-sensitizing and resistant EGFR mutations in an untreated lung adenocarcinoma patient and response to erlotinib. Journal of Thoracic Oncology 9: e55-7, No. 7, Jul 2014. Available from: URL: http://doi.org/10.1097/JTO.0000000000000197 - USACrossRefPubMedGoogle Scholar
Copyright information
© Springer International Publishing Switzerland 2015